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Inactivation of branched-chain 2-oxoacid ehydrogenase complex correlates with phosphorylation atone 
site on the cy subunit of the El component. The amino acid sequence surrounding this phosphorylated 
serine residue has now been determined. This sequence shows certain similarities with the sequence 
surrounding phosphorylated residue(s) on pyruvate dehydrogenase complex. 
Branched-chain 2-oxoacid dehydrogenase complex Phosphorylation site 
(Bovine kidney cortex) 
Amino acid sequence 
1. INTRODUCTION 2. MATERIALS AND METHODS 
The activity of the mitochondrial branched-chain 
2-oxoacid dehydrogenase complex is regulated by 
covalent phosphorylation [ 11. Phosphorylation of 
the LY subunit of the El component by a protein 
kinase intrinsic to the complex causes complete 
loss of activity [2-41. 
We have reported previously that three distinct 
sites on the LY subunit are phbsphorylated by the 
kinase. These phosphorylation sites are recovered 
on 3 tryptic peptides designated Tl , T2 and T3. In- 
activation correlates closely with phosphorylation 
of one site [5]. We here report isolation of the tryp- 
tic phosphopeptide Tl containing this site and we 
have determined the amino acid sequence surroun- 
ding the phosphorylated serine residue. Homology 
with the reported sequence surrounding the phos- 
phorylation sites on pyruvate dehydogenase com- 
plex [6,7] is discussed. 
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2. I . Materials 
Bovine kidney branched-chain 2-oxoacid de- 
hydrogenase complex, with endogenous kinase 
activity, was purified, phosphorylated and de- 
salted as in [4,5]. Trypsin (TPCK-treated) was 
from Worthington, subtilisin from Sigma and 
[Y-~*P]ATP was synthesised as in [8]. 
2.2. Digestion with proteases 
Phosphorylated branched-chain 2-oxoacid de- 
hydrogenase (25 mg) was digested with trypsin 
(0.5 mg) for 30 min at 20°C in 0.2 M NfiHCO3 
(pH 8.4). Phosphopeptide Tl (24nmol) was sub- 
digested with subtilisin (IOOpg) for 5 h at 37°C in 
0.1 M NHdHCO3 (pH 7.8). This digestion was ter- 
minated by lyophilisation and the sub-peptides 
were purified by reverse phase HPLC. 
2.3. Purification of peptides 
High voltage paper electrophoresis at pH 1.9 was 
carried out as in [5]. Two-dimensional peptide map- 
ping on cellulose sheets was as in [9]. This involved 
electrophoresis in pyridineiacetic acid/water (pH 
3.5), followed by ascending chromatography in 
pyridine/acetic acid/water/butanol (10 : 3 : 12 : 15). 
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Peptides were also purified by HPLC on a Waters 
bbondapak C~S reverse-phase HPLC column [lo]. 
A linear gradient (O-40%) of water/acetonitrile, 
containing 0.1% trifluoroacetic acid, was used, 
with an increase in acetonitrile concentration of 
1 %/min. The flow rate was 1 .O ml/min and 0.5 ml 
fractions were collected. The effluent was moni- 
tored at 215 nm and by Cerenkov counting for 32P- 
labelled peptides. 
2.4. Amino acid and automatic sequencer analysis 
Amino acid analyses were carried out on an LKB 
Biochrom 4400 amino acid analyser. Automatic 
sequencer analysis was done on a Beckman 890C 
sequencer using a 0.2 M quadrol programme. Poly- 
brene (2 mg) and heparin (2 mg) were added to the 
sequencer cup to help prevent washout of peptides. 
Conversion to Pth derivatives was by incubation 
with 20% trifluoroacetic acid for 8 min at 80°C. 
Residues were identified by HPLC and by back- 
hydrolysis [9, lo]. To identify the phosphorylated 
species in phosphopeptides, partial acid hydrolysis 
was carried out for 2 h at 110°C in 6 N HCl and the 
products separated by high voltage electrophoresis 
at pH 1.9. 
3. RESULTS 
3.1. Purification of peptide Tl from branched- 
chain 2-oxoacid dehydrogenase 
Following tryptic digestion of phosphorylated 
branched-chain 2-oxoacid dehydrogenase, the 
digestion was terminated by addition of 0.1 vol. 
100% (w/v) trichloroacetic acid. After standing 
for 10min on ice, the mixture was centrifuged at 
10000 x g for 2 min. The supernatant, containing 
over 95% of the initial radioactivity but only 15% 
of the initial protein (as judged by absorbance at 
280nm), was extracted 5 times with diethyl ether 
and lyophilised. Alternatively digestion was termi- 
nated by lyophilisation and the phosphopeptides 
were separated by high voltage electrophoresis at 
pH 1.9. After autoradiography the peptides were 
eluted in 7% (v/v) formic acid and lyophilised. 
Further purification was achieved by reverse 
phase HPLC. Peptide Tl emerged as one major 
peak of radioactivity at 24% acetonitrile. It was 
then subjected to two-dimensional peptide map- 
ping. Tl was detected by autoradiography and 
eluted in 1.0 M acetic acid. Staining of the map 
with fluorescamine indicated that Tl was free of 
contaminating peptides. 
Table 1 
Amino acid composition of peptides 
Amino acid Tryptic 
peptide Tl 
Subtilisin peptides 
Tl, Tlb I-1, 
Aspartic acid 1.85(2) 
Threonine 1.05(l) 
Serine 3.76(4) 
Glycine 1.12(l) 
Alanine 0.98(l) 
Isoleucine 1.04(l) 
Tyrosine 1.18(l) 
Histidine 1.80(2) 
Arginine 0.99(l) 
Residues 
“P-Radioactivity 
14 
+ 
1.36(l) 
1.87(2) 0.25(O) 
0.98(l) 0.30(O) 
1.30(l) 
0.89(l) 
1.07(l) 
2.13(2) 
0.69( 1) 
4 3 3 
- + _ 
Peptides were hydrolysed for 24 h at 110°C in 6 N HCl containing 2 mM phenol. 
Values for serine and threonine were corrected for 10 and 5% destruction, 
respectively 
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Table 2 
Automatic sequencer analysis of peptides 
Step Peptide Tl (20nmol) Peptide Tl, 
HPLC Amino acid analysis 
(18 nmol) 
HPLC 
1 Be 
2 Gly 
3 His 
4 His 
5 Ser 
6 Thr 
7 Ser 
8 Asp 
9 Asp 
10 Ser 
11 - 
12 Ala 
13 Tyr 
14 - 
Be (11.8) 
Gly (13.3) 
His (2.8) 
His (2.5) 
Ala (1.0) 
cu-Aba (2.0) 
Ala (0.9) 
Asp (1.7) 
Asp (1.6) 
Ala (1.0) 
- 
- 
- 
- 
Ala 
Tyr 
Ar8 
Serine and threonine were identified as alanine and 
cu-aminobutyric acid (Lu-aba) respectively, on amino acid 
analysis following back hydrolysis. Figures in paren- 
theses indicate recovery in nmol 
3.2. Sequence analysis of peptide TI 
Amino acid analysis of the phosphopeptide Tl 
indicated that it consists of 14 residues (table 1). 
Automatic sequencer analysis allowed residues 
l-10 to be identified by HPLC and amino acid 
analysis after hydrolysis (table 2). Residues 12 and 
13 were identified by HPLC. The sequencer analy- 
sis was carried out twice. As Tl is a tryptic phos- 
phopeptide containing only a single arginine this 
would be expected to be at the carboxyl terminus 
of the peptide, namely residue 14. The sequence of 
residues 12- 14 was confirmed by analysis of a sub- 
tilisin sub-fragment Tl, (tables 1,2). No residue 
was positively identified at position 11, although a 
trace of Pth-dehydroalanine was detected by 
HPLC. This breakdown product of Pth-serine has 
a characteristic absorbance at 313 nm. As amino 
acid analysis of Tl indicated the presence of 4 
serine residues and as all other residues and 3 of 
the serine residues were positively assigned other 
positions in Tl, it was concluded that residue 11 
was serine. The complete sequence of Tl is shown 
in table 3. 
3.3. Identification of the phosphorylated residue 
of TI 
Partial acid hydrolysis of Tl (and of T2 and T3) 
followed by high voltage electrophoresis at pH 1.9 
showed the presence of phosphoserine. No phos- 
phothreonine or phosphotyrosine was detected 
(not shown). Automatic sequencer analysis of Tl 
showed that a peak of “P-radioactivity was re- 
leased at the fifth cycle. No other peak was ob- 
served (fig.1). The serine residue at position 5 was 
llllL_ 
i 7 8 9 10 11 12 13 14 
Cycle No. 
Fig. 1. Automatic sequencer analysis of peptide Tl. 32P- 
radioactivity extracted from the sequencer cup into butyl 
chloride at each cycle of Edman degradation, was deter- 
mined by Cerenkov counting. 
Table 3 
Amino acid sequences at the major (inactivating) phosphorylation site on branched-chain 2-oxoacid dehydrogenase and 
pyruvate dehydrogenase complexes 
Protein Sequence 
Branched-chain 2-oxoacid dehydrogenase (this work) Ile-Gly-His-His-Ser(P)-Thr-Ser-Asp-Asp-Ser-Ser-Ala-Tyr-Arg 
Pyruvate dehydrogenase [6,7] Tyr-His-Gly-His-Ser(P)-Met-Ser-Asx-Pro-Gly-Val-Ser-Tyr-Arg 
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confirmed as the only p~osphor~lat~d residue in nary analysis of T3 indicates that it is a distinct 
Tl by sub-digestion with subtilisin. Three sub- peptide from Tl and T2. 
peptides were recovered by HPLC (table f), only Knowledge of the primary structure surrounding 
one of which, T~L,, was radioa&tive. This peptide the phosphorylation sites wili facilitate further de- 
corresponds to residues 5-7 of Tl. After one cycle tailed investigation of the covalent regulation of 
of Edman degradation, all the radioactivity was the branched-chain 2-oxoacid dehydrogenase. Of 
removed from Tlb and was detected as inorganic particular interest will be studies using synthetic 
[32P] phosphate following paper electrophoresis at peptides to investigate the specificity requirements 
pH 1.9 and autoradiography. It is therefore con- of the respective kinases and phosphatases which 
cluded that Ser-5 is the only phosphorylated resi- act on the branched-chain 2-oxoacid dehydrogen- 
due in the phosphopeptide Tl. ase and pyruvate dehydrogenase complexes. 
4. DISCUSSION ACKNOWLEDGEMENTS 
Inactivation of branched-chain 2-oxoacid dehyd- 
rogenase complex correlates closely with phos- 
phoryfation of one site on the LY subunit of the Et 
component [S]. We report here the amino acid 
sequence surrounding the phosphor~latable serine 
residue. This sequence shows considerable hom- 
ology with the sequence surrounding the serine resi- 
due on pyruvate dehydrogenase complex (table 3), 
phosphorylation of which causes inactivation of 
that complex f6,7]. Six of the 14 residues in the 
tryptic phosphopeptides are identical. Further- 
more 4 of the 5 residues immediately surrounding 
the phosphorylated serine are identical in both 
complexes. 
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